Nobio
Petah Tiqva
About Nobio
NobioTM developed game-changing technology with the goal to prevent medical device contamination indefinitely, as the first and only fully-integrated anti-biofilm solution. The technology core consists of extremely potent particles which are covered with a high concentration of highly-active anti-microbial structures that kill bacteria upon contact. The NobioTM particles can be permanently embedded in many products and materials to inhibit formation of biofilm, indefinitely.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $3.8M
- Last round: Grant (Apr 2020)
- Website: nobio.com
- Phone: +972-3-9059966
Industries & Categories
Biotechnology, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/nobio-61305 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.